Boqii vs Pomdoctor
BQ and POM side by side, both in miscellaneous retail. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How BQ and POM compare
Pomdoctor grew revenue faster over the last twelve months (16.7% versus −10.3% for Boqii).
Boqii scores higher on the StockData Score (7 against 1 for Pomdoctor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | BQ | POM |
|---|---|---|
| Size and price | ||
| Share price | $0.420 | $1.62 |
| Change, 1 year | −83.8% | −98.3% |
| Change, 5 years | −99.9% | – |
| Beta (5Y) | 1.59 | 1.22 |
| Employees | 9 | 10K |
| StockData Score | ||
| Total score | 7 (better) | 1 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 3 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −10.3% | 16.7% (better) |
| Revenue growth, 5Y average | −16.1% | – |
| Profitability | ||
| Gross margin | 26.3% (better) | 13.1% |
| Operating margin | −7.1% (better) | −29.7% |
| Net margin | −1.2% | – |
| FCF margin | −7.2% (better) | −37.4% |
| Return on equity | −2.7% | – |
| Return on invested capital | −15.2% | – |
| Financial health | ||
| Debt / equity | 0.09 | – |
| Interest coverage | −36.3× | −30.1× (better) |
| Current ratio | 3.25 (better) | 0.35 |
| Piotroski F-score | 4 | – |
| Ownership | ||
| Held by institutions | – | 0.11% |
| Held by insiders | 10.3% | 28.1% |
Go deeper
- BQ stock overview
- BQ income statement
- BQ valuation and score
- POM stock overview
- POM income statement
- POM valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.